RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling

被引:0
|
作者
Hu, Sheng [1 ]
Zhang, Yijie [2 ]
Qiu, Chenming [3 ,5 ]
Li, Ying [2 ,4 ]
机构
[1] Gen Hosp Western Theater Command, Dept Pulm & Crit Care Med, Chengdu, Peoples R China
[2] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Burn, Chengdu, Peoples R China
[4] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu 610083, Peoples R China
[5] Gen Hosp Western Theater Command, Dept Burn, Chengdu 610083, Peoples R China
关键词
RGS10; AKT; mTORC1; pulmonary arterial smooth muscle cell; pulmonary hypertension; MAMMALIAN TARGET; MTORC1; HYPERPLASIA; SUPPRESSES;
D O I
10.1080/10641963.2023.2271186
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Excessive proliferation and migration of pulmonary arterial smooth muscle cell (PASMC) is a core event of pulmonary hypertension (PH). Regulators of G protein signaling 10 (RGS10) can regulate cellular proliferation and cardiopulmonary diseases. We demonstrate whether RGS10 also serves as a regulator of PH.Methods: PASMC was challenged by hypoxia to induce proliferation and migration. Adenovirus carrying Rgs10 gene (Ad-Rgs10) was used for external expression of Rgs10. Hypoxia/SU5416 or MCT was used to induce PH. Right ventricular systolic pressure (RVSP) and right ventricular hypertrophy index (RVHI) were used to validate the establishment of PH model.Results: RGS10 was downregulated in hypoxia-challenged PASMC. Ad-Rgs10 significantly suppressed proliferation and migration of PASMC after hypoxia stimulus, while silencing RGS10 showed contrary effect. Mechanistically, we observed that phosphorylation of S6 and 4E-Binding Protein 1 (4EBP1), the main downstream effectors of mammalian target of rapamycin complex 1 (mTORC1) as well as phosphorylation of AKT, the canonical upstream of mTORC1 in hypoxia-induced PASMC were negatively modulated by RGS10. Both recovering mTORC1 activity and restoring AKT activity abolished these effects of RGS10 on PASMC. More importantly, AKT activation also abolished the inhibitory role of RGS10 in mTORC1 activity in hypoxia-challenged PASMC. Finally, we also observed that overexpression of RGS10 in vivo ameliorated pulmonary vascular wall thickening and reducing RVSP and RVHI in mouse PH model.Conclusion: Our findings reveal the modulatory role of RGS10 in PASMC and PH via AKT/mTORC1 axis. Therefore, targeting RGS10 may serve as a novel potent method for the prevention against PH."
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells
    Wang, Jinhua
    Lian, Guili
    Luo, Li
    Wang, Tingjun
    Xu, Changsheng
    Wang, Huajun
    Xie, Liangdi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 64
  • [22] Attenuation of Pulmonary Arterial Smooth Muscle Cell Proliferation Following Hypoxic Pulmonary Hypertension by the Na+/H+ Exchange Inhibitor Amiloride
    Liu, Yi
    Zhang, Bo
    Dong, Ming-qing
    Niu, Wen
    Luo, Ying
    Gao, Yu-qi
    Li, Zhi-chao
    CHINESE JOURNAL OF PHYSIOLOGY, 2010, 53 (01): : 36 - 44
  • [23] AMPKα2 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation
    Wang, Hai-Long
    Tang, Fu-Qin
    Jiang, Yun-Han
    Zhu, Yu
    Jian, Zhao
    Xiao, Ying-Bin
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2020, 76 (03) : 445 - 456
  • [24] RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension
    Hu, Sheng
    Zhao, Youguang
    Qiu, Chenming
    Li, Ying
    BIOENGINEERED, 2022, 13 (02) : 3516 - 3526
  • [25] AMPKα2 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation
    Hai-Long Wang
    Fu-Qin Tang
    Yun-Han Jiang
    Yu Zhu
    Zhao Jian
    Ying-Bin Xiao
    Journal of Physiology and Biochemistry, 2020, 76 : 445 - 456
  • [26] PDGF-dependent -catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
    Takahashi, Jack
    Orcholski, Mark
    Yuan, Ke
    Perez, Vinicio de Jesus
    FEBS LETTERS, 2016, 590 (01) : 101 - 109
  • [27] Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway
    Nie, Xiaowei
    Tan, Jianxin
    Dai, Youai
    Mao, Wenjun
    Chen, Yuan
    Qin, Guowei
    Li, Guirong
    Shen, Chenyou
    Zhao, Jingjing
    Chen, Jingyu
    VASCULAR PHARMACOLOGY, 2016, 87 : 230 - 241
  • [28] Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
    Perros, F.
    Dorfmuller, P.
    Souza, R.
    Durand-Gasselin, I.
    Godot, V.
    Capel, F.
    Adnot, S.
    Eddahibi, S.
    Mazmanian, M.
    Fadel, E.
    Herve, P.
    Simonneau, G.
    Emilie, D.
    Humbert, M.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (05) : 937 - 943
  • [29] Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration
    Song, Jia-Lin
    Zheng, Si-Yi
    He, Rui-Lan
    Gui, Long-Xin
    Lin, Mo-Jun
    Sham, James S. K.
    VASCULAR PHARMACOLOGY, 2021, 138
  • [30] Suppression of HIF-1 α-mediated PDGFBB Signaling Inhibits the Hypertrophy of Pulmonary Arterial Smooth Muscle Cell In Vitro and In Vivo
    Ke, Meng-Wei
    Cheng, Chin-Chang
    Huang, Wei-Chun
    Wann, Shue-Ren
    Shu, Chih-Wen
    Tseng, Ching-Jiunn
    Mar, Guang-Yuan
    Liu, Chun-Peng
    CIRCULATION RESEARCH, 2016, 119 (12) : E170 - E170